This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NUVA NuVasive (NUVA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About NuVasive Stock (NASDAQ:NUVA) 30 days 90 days 365 days Advanced Chart Get NuVasive alerts:Sign Up Key Stats Today's Range$39.75▼$39.7550-Day Range$38.12▼$40.6652-Week Range$35.17▼$49.53VolumeN/AAverage Volume1.16 million shsMarket Capitalization$2.08 billionP/E Ratio79.50Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc. Read More Receive NUVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuVasive and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NUVA Stock News HeadlinesGlobus Medical (GMED) Shares Skyrocket, What You Need To KnowAugust 8, 2025 | msn.comThe 5 Most Interesting Analyst Questions From Globus Medical’s Q1 Earnings CallJuly 1, 2025 | msn.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. August 27 at 2:00 AM | Crypto 101 Media (Ad)BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business ConcernsMay 27, 2025 | msn.comGlobus Medical targets $2.8B-$2.9B revenue in 2025 with Nevro acquisition integrationFebruary 21, 2025 | msn.comGlobus Medical: Some Caution After Its Deal For NevroFebruary 16, 2025 | seekingalpha.comGlobus acquisition of Nevro complicates story, says StifelFebruary 6, 2025 | markets.businessinsider.comBTIG maintains $91 target on Globus Medical stock post-acquisitionFebruary 6, 2025 | msn.comSee More Headlines NUVA Stock Analysis - Frequently Asked Questions How were NuVasive's earnings last quarter? NuVasive, Inc. (NASDAQ:NUVA) released its quarterly earnings data on Wednesday, August, 2nd. The medical device company reported $0.56 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.56. NuVasive's quarterly revenue was up 2.4% on a year-over-year basis. Read the conference call transcript. Does NuVasive have any subsidiaries? The following companies are subsidiaries of NuVasive: Simplify Medical, SafePassage, Vertera Spine, Biotronic NeuroNetwork, Ellipse Technologies, NuVasive Clinical Services Monitoring Inc., NuVasive Japan KK, NuVasive Specialized Orthopedics Inc., and NuVasive Technology International Limited. What other stocks do shareholders of NuVasive own? Based on aggregate information from My MarketBeat watchlists, some other companies that NuVasive investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), First Solar (FSLR), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD). Company Calendar Last Earnings8/02/2023Today8/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:NUVA CIK1142596 Webwww.nuvasive.com Phone(858) 909-1800Fax800-475-9134Employees3,000Year Founded1997Profitability EPS (Trailing Twelve Months)$0.50 Trailing P/E Ratio79.50 Forward P/E Ratio17.91 P/E GrowthN/ANet Income$40.41 million Net Margins2.32% Pretax Margin3.41% Return on Equity12.17% Return on Assets4.88% Debt Debt-to-Equity Ratio0.50 Current Ratio1.25 Quick Ratio0.65 Sales & Book Value Annual Sales$1.23 billion Price / Sales1.70 Cash Flow$4.96 per share Price / Cash Flow8.01 Book Value$17.02 per share Price / Book2.34Miscellaneous Outstanding Shares52,449,000Free Float52,171,000Market Cap$2.08 billion OptionableOptionable Beta1.07 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:NUVA) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuVasive, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NuVasive With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.